Latest colorectal cancer News | Page 2

Climate change impact on youth mental health explored
Artificial intelligence to predict chemotherapy toxicities in colon cancer patients
Carina Biotech to present details of planned trial of CAR-T cell therapy candidate
Time is running out: patients, physicians brace for anticipated delays, denials by UnitedHealthcare for endoscopies starting June 1
Time is running out: patients, physicians brace for anticipated delays, denials by UnitedHealthcare for endoscopies starting June 1
First patient on trial in colorectal, gastric and ovarian cancer study
Meat, eggs and milk essential source of nutrients especially for most vulnerable groups, new FAO report says
12 world-class cancer research projects helping us reach a cancer free future, sooner
Personalized Gut Microbiome Analysis for Colorectal Cancer Classification with Explainable AI
Using right test for right person to detect bowel cancer
Treatment options close to home for Albany cancer patients
Two Ludwig Cancer Research studies reveal essential role of neutrophils in immunotherapy
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
3D bioprinting inside the human body could be possible thanks to new soft robot
GTG to form strategic alliance with global testing leader QIAGEN
Ludwig Harvard imaging study reveals cellular, molecular and structural complexity of colorectal tumors
Does eating processed meats cause colorectal cancer?
Support for home cancer testing
Small Changes Can Have Big Impact on Health
Researchers identify ‘born to be bad’ colorectal cancer tumours
Colorectal Cancer Tumors with ‘Born to be Bad’ Genes Identified
Potential therapy for aggressive type of colon cancer shows promise
Hesitation towards potential changes to bowel cancer surveillance
Precision medicine trial opens for rare adult and paedatric cancers
Long serving CSIRO Chief Executive Dr Larry Marshall to conclude third and final term June 2023
Enhertu recommended for approval in EU by CHMP for patients with previously treated HER2-positive advanced gastric cancer
New melanoma breakthrough by Australian company could potentially save thousands of lives
What are postbiotics and how can they improve our gut health?
Imjudo in combination with Imfinzi approved in US for patients with unresectable liver cancer
Going with your gut
Guidelines on breast cancer surgery need revision, find researchers
Success for University of Otago, Christchurch, Researchers with CMRF Major Project Grant
Researchers explore use of light-activated treatment to target wider variety of cancers
New technique boosts online medical search results
New Study Links Ultra-Processed Foods and Colorectal Cancer in Men
Are Costly New Prescription Drugs Worth Price?
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment
Enhertu granted Priority Review in US for patients with HER2-low metastatic breast cancer
Scientists identify key molecular protector of gut health
AGA to join Fight CRC at White House to address colorectal cancer screening needs
Pat Morin appointed deputy scientific director of Ludwig Institute for Cancer Research
Gut bacteria potential key to IBD and colon cancer prevention
Enhertu recommended for approval in EU by CHMP for patients with HER2-positive metastatic breast cancer treated with prior
AGA releases evidence-based principles to guide creation of national colorectal cancer screening approach
‘The Rock’ assumes presidency of AGA
New cancer subtype may illuminate treatment strategy
Radiation oncology services in Albany to be provided by GenesisCare
$900,000 funding for Otago health researchers